GlycoMimetics Appoints Scott Koenig of MacroGenics to Board of Directors
Two Long-Time Board Members to Step Down After Company's 2017 Annual Meeting
"We are delighted to have someone with the breadth and depth of Dr.
Koenig's scientific and business expertise join our Board of Directors
as we move our portfolio of product candidates into later stages of
clinical development and closer to commercialization," said
"I'm honored to serve on the Board of Directors of
In addition to the appointment of
"I am so grateful for the insights and contributions that Drs. Top and
Baldwin have provided to the
About
GlycoMimetics is a clinical-stage biotechnology company focused on
cancer and sickle cell disease.
Forward-Looking Statements
This press release contains forward-looking statements regarding
GlycoMimetics' planned activities with respect to the clinical
development of its drug candidates, GMI-1271 and GMI-1359. Actual
results may differ materially from those indicated by such
forward-looking statements as a result of various important factors,
including the availability and timing of data from ongoing clinical
trials, the uncertainties inherent in the initiation of future clinical
trials, whether interim results from a clinical trial will be predictive
of the final results of the trial or results of early clinical trials
will be indicative of the results of future trials, expectations for
regulatory approvals, availability of funding sufficient for
GlycoMimetics' foreseeable and unforeseeable operating expenses and
capital expenditure requirements, other matters that could affect the
availability or commercial potential of GlycoMimetics' drug candidates
and other factors discussed in the "Risk Factors" section of
GlycoMimetics' Annual Report on Form 10-K that was filed with the
View source version on businesswire.com: http://www.businesswire.com/news/home/20170313005681/en/
Investor Contact:
650-888-0902
sannes@annesassociates.com
or
Media
Contact:
410-299-3310
jamielacey@presscommpr.com
Source:
News Provided by Acquire Media